A prospective observational study of injection pain in children with medium plus long chain triglyceride and long chain triglyceride propofol premixed with lignocaine
- PMID: 29643556
- PMCID: PMC5881324
- DOI: 10.4103/ija.IJA_506_17
A prospective observational study of injection pain in children with medium plus long chain triglyceride and long chain triglyceride propofol premixed with lignocaine
Abstract
Background and aims: Propofol injection pain is an unresolved problem in children. Although medium and long chain triglyceride (MCT-LCT) propofol has shown promising results in adults, its efficacy in children is not proven. In a prospective observational study the incidence and severity of pain with MCT-LCT and LCT propofol in children was compared.
Methods: After obtaining approval from the Institutional Ethics Committee, 170 children (age group 6 months to 8 years) scheduled for various surgeries were included in this study. Following standard pre-medication, propofol 1% either LCT or MCT-LCT in a dose of 2-4 mg/kg along with preservative-free lignocaine (2% lignocaine 1 mg in propofol 10 mg) was administered. The primary objective was to study injection pain on scale of 0-6. For children ≤2 years doubling of motor event score (0-3) and for children >2 years, addition of motor (0-3) and verbalisation scores (0-3) were considered. Mann-Whitney U test was used for statistical analysis.
Results: MCT-LCT group had lower incidence of pain (17 patients (20%) versus 35 patients (35.3%), P = 0.026) and severe pain (zero patients (0%) versus six patients (7.1%), P = 0.029) as compared to LCT group. MCT-LCT group had significantly lower mean rank of motor (79.65 versus 91.35), verbal (77.29 versus 90.79) and total score (77.76 versus 93.24) as compared to LCT group (P = 0.037, 0.002, and 0.009, respectively).
Conclusion: MCT-LCT propofol is associated with significantly lower injection pain as compared to LCT propofol in children, when both are combined with lignocaine.
Keywords: Children; injection; lignocaine; pain; propofol; triglyceride.
Conflict of interest statement
There are no conflicts of interest.
References
-
- Ohmizo H, Obara S, Iwama H. Mechanism of injection pain with long and long-medium chain triglyceride emulsive propofol. Can J Anaesth. 2005;52:595–9. - PubMed
-
- Larsen R, Beerhalter U, Erdkönig R, Larsen B. Injection pain from propofol-MCT-LCT in children. A comparison with propofol-LCT. Anaesthesist. 2001;50:676–8. - PubMed
-
- Varghese E, Krishna HM, Nittala A. Does the newer preparation of propofol, an emulsion of medium/long chain triglycerides cause less injection pain in children when premixed with lignocaine? Paediatr Anaesth. 2010;20:338–42. - PubMed
-
- Nyman Y, von Hofsten K, Georgiadi A, Eksborg S, Lönnqvist PA. Propofol injection pain in children: A prospective randomized double-blind trial of a new propofol formulation versus propofol with added lidocaine. Br J Anaesth. 2005;95:222–5. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
